About
Us
Handok, the total healthcare company.
Handok
Product
Pipelines
Pipelines
Look into the wide range of our products.
-
PR
Handok Obtains Domestic Approval for New Drug Pivlaz to Prevent Cerebral Vasospasm in Patients with Subarachnoid Hemorrhage
Handok announced on December 7, 2023, that Pivlaz, a new drug for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage, has been approved by the Korean Minis..
2023.12.07 -
PR
Handok Wins Health and Welfare Minister’s Innovative Pharmaceutical Company Award
On November 27, Handok received the Innovative Pharmaceutical Company Award from the Korean Ministry of Health and Welfare (MOHW). The MOHW annually recognizes innovative pharmaceutical com..
2023.12.01